PUBLICAÇÕES científicas

Emerging clinical issues and multivariate analyses in PET investigations

Arbizu J (1), Giuliani A (2), Perez-Larraya JG (3), Riverol M (3), Jonsson C (4), García-García B (5), Morales M (5), Imaz L (3), Pagani M (6,7). (1) Department of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain
(2) Environment and Health Department, Istituto Superiore di Sanità, Rome, Italy.
(3) Department of Neurology, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain.
(4) Medical Radiation Physics and Nuclear Medicine, Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden.
(5) Department of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain.
(6) Institute of Cognitive Sciences and Technologies, CNR, Rome, Italy.
(7) Department of Nuclear Medicine, Karolinska Hospital Stockholm, Stockholm, Sweden.

Revisão:The quarterly journal of nuclear medicine and molecular imaging

Data: 27/Jul/2017

Neurologia [ES] Medicina Nuclear [ES]

RESUMO

PET using 18F-2-fluoro-2-deoxy-D-glucose (FDG-PET) has been gradually introduced in the diagnostic clinical criteria of the most prevalent neurodegenerative diseases.

Moreover, an increasing amount of literature have shown that the information provided by FDG-PET enhances the sensitivity of standard imaging biomarkers in less frequent disorders in which an early differential diagnosis can be of paramount relevance for patient management and outcome.

Therefore emerging uses of FDG-PET may be important in prion diseases, autoimmune encephalitis and amyotrophic lateral sclerosis. Interestingly, FDG-PET findings can also be observed in early phases of these conditions, even in the presence of normal MRI scans.

Thalamic hypometabolism is a common finding in sporadic Creutzfeldt-Jacob disease and fatal familiar insomnia patients, with further cortical synaptic dysfunction in the former. Limbic and extra-limbic metabolic abnormalities (more often hypermetabolism) can be observed in autoimmune encephalitis, although specific patterns may be seen within different syndromes associated with antibodies that target neuronal surface or synaptic antigens. FDG-PET shows its usefulness by discriminating patients with amyotrophic lateral sclerosis associated to upper motor neuron onset that evolve in frontotemporal dementia.

Besides visual and voxel based image analysis, multivariate analysis as interregional correlation analysis and independent/principal component statistical analysis have been successfully implemented for PET images increasing the accuracy of the discrimination of neurodegenerative diseases.

The clinical presentation and current diagnostic criteria of these neurologic disorders as well as the emerging usefulness of FDG-PET in the diagnostic workup are presented and discussed in this review.

CITAÇÃO DO ARTIGO  Q J Nucl Med Mol Imaging. 2017 Jul 27. doi: 10.23736/S1824-4785.17.03024-2

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra